In murine models of hepatocellular carcinoma arising in nonalcoholic fatty liver disease, CD154-positive platelets are essential for limiting tumor growth and genetic or pharmacologic loss of CD154 abolishes this effect, whereas transfusion of CD154-expressing platelets restores it [95]. The gene discussed is CD40LG; the disease is metabolic dysfunction-associated steatotic liver disease.